Imuraya Group Company Limited operates within the Candy & other confectionery products sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Imuraya Group Company Limited with three other
bakery and confectionary companies in Asia:
GlaxoSmithKline Consumer Healthcare Limited
sales of 39.86 billion Indian Rupees [US$616.31 million]
of which 100%
Ismail Industries Limited
(19.60 billion Pakistan Rupees [US$186.25 million]
Nakamuraya Co., Ltd.
(41.90 billion Japanese Yen [US$374.59 million]
of which 71%
was Confectionery Business).
During the year ended March of 2017, sales at
Imuraya Group Company Limited were ¥42.00 billion (US$375.46 million).
increase of 8.7%
versus 2016, when the company's sales were ¥38.64 billion.
This was the fifth consecutive year of sales increases at Imuraya Group Company Limited
(and since 2012, sales have increased a total of 29%).
Sales of Distribution Business saw an increase
8.9% in 2017, from
¥33.85 billion to ¥36.87 billion.